PE20060695A1 - Epotilonas en el tratamiento de metastasis osea - Google Patents
Epotilonas en el tratamiento de metastasis oseaInfo
- Publication number
- PE20060695A1 PE20060695A1 PE2005001103A PE2005001103A PE20060695A1 PE 20060695 A1 PE20060695 A1 PE 20060695A1 PE 2005001103 A PE2005001103 A PE 2005001103A PE 2005001103 A PE2005001103 A PE 2005001103A PE 20060695 A1 PE20060695 A1 PE 20060695A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- aryl
- aralkyl
- epotilones
- metastasis
- Prior art date
Links
- 206010027476 Metastases Diseases 0.000 title abstract 2
- 230000009401 metastasis Effects 0.000 title abstract 2
- 239000004593 Epoxy Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
SE REFIERE A UNA EPOTILONA DE FORMULA I, DONDE R1a, R1b SON CADA UNO H, ALQUILO C1-C10, ARILO, ARALQUILO, ENTRE OTROS; R2a, R2b SON CADA UNO H, ARILO, ALQUENILO C2-C10, ALQUILO C1-C10, ENTRE OTROS; R3 ES H, ALQUILO C1-C10, ARILO, ARALQUILO; R4a, R4b SON CADA UNO H, ALQUILO C1-C10, ARILO, ARALQUILO, ENTRE OTROS; R5 ES H, ALQUILO C1-C10, ARILO, ARALQUILO, CO2ALQUILO, CH2OH, CN, ENTRE OTROS; R6, R7 SON CADA UNO H, O FORMAN JUNTOS UNA UNION ADICIONAL O FORMAN UNA UNION EPOXI; G ES O, CH2; D-E JUNTOS SON -H2C-CH2-, -HC=CH-, CH(OH)-CH(OH)-, -O-CH2-, ENTRE OTROS; W ES C(=X)R8, AROMATICO, HETEROAROMATICO BI O TRICICLICO; X ES O, O(ALQUILO C1-C20), ENTRE OTROS; R8 ES H, ALQUILO C1-C10, ARILO, ARALQUILO, ENTRE OTROS; Z ES DE PREFERENCIA O, H; A-Y ES O-C(=O), O-CH2, CH2-C(=O), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (4S,7R,8S,9S,13E/Z,16S)-4,8-DIHIDROXI-16-(2-METIL-BENZOXAZOL-5-IL)-1-OXA-5,5,9,13-TETRAMETIL-7-(PROP-2-EN-1-IL)-CICLOHEXADEC-13-ENO-2,6-DIONA; (1S/R,3S(E),7S,10R,11R,12R,16R/S)-7,11-DIHIDROXI-10-(PROP-2-EN-1-IL)-3-(2-METIL-BENZOXAZOL-5-IL)-8,8,12,16-TETRAMETIL-4,17-DIOXABICICLO[14.1.0]HEPTADECANO-5,9-DIONA; ENTRE OTROS. DICHAS EPOTILONAS SON INHIBIDORES DE LA METASTASIS EN HUESO Y CRECIMIENTO TUMORAL EN HUESOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04090377A EP1640004A1 (en) | 2004-09-24 | 2004-09-24 | Use of epothilones in the treatment of bone metastases and bone tumors or cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060695A1 true PE20060695A1 (es) | 2006-08-03 |
Family
ID=34928830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005001103A PE20060695A1 (es) | 2004-09-24 | 2005-09-23 | Epotilonas en el tratamiento de metastasis osea |
Country Status (21)
| Country | Link |
|---|---|
| EP (2) | EP1640004A1 (es) |
| JP (1) | JP2008514569A (es) |
| KR (1) | KR20070054214A (es) |
| CN (1) | CN101065126A (es) |
| AR (1) | AR051035A1 (es) |
| AU (1) | AU2005287477A1 (es) |
| BR (1) | BRPI0516080A (es) |
| CA (1) | CA2580215A1 (es) |
| CR (1) | CR9064A (es) |
| EC (1) | ECSP077390A (es) |
| GT (1) | GT200500267A (es) |
| IL (1) | IL181785A0 (es) |
| MX (1) | MX2007003503A (es) |
| NO (1) | NO20072099L (es) |
| PA (1) | PA8646201A1 (es) |
| PE (1) | PE20060695A1 (es) |
| RU (1) | RU2007115162A (es) |
| TW (1) | TW200626150A (es) |
| UY (1) | UY29136A1 (es) |
| WO (1) | WO2006032537A2 (es) |
| ZA (1) | ZA200703306B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1930004A1 (en) * | 2006-12-08 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Use of epothilones in the treatment of osteoporosis and related diseases |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605599B1 (en) * | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
| FR2775187B1 (fr) * | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
| PT1140944E (pt) * | 1998-12-22 | 2004-01-30 | Novartis Pharma Gmbh | Derivados de epotilona e sua utilizacao como agentes antitumorais |
| PE20010116A1 (es) * | 1999-04-30 | 2001-02-15 | Schering Ag | Derivados de 6-alquenil-, 6-alquinil- y 6-epoxi-epotilona, procedimientos para su preparacion |
| EP2289549A3 (en) * | 1999-10-01 | 2011-06-15 | Immunogen, Inc. | Immunoconjugates for treating cancer |
| JP2004508810A (ja) * | 2000-04-28 | 2004-03-25 | コーサン バイオサイエンシーズ， インコーポレイテッド | ポリケチドの生成 |
| UA75365C2 (en) * | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
| AU2002338336A1 (en) * | 2001-04-03 | 2002-10-21 | Kosan Biosciences, Inc. | Epothilone derivatives and methods for making and using the same |
| TWI315982B (en) * | 2001-07-19 | 2009-10-21 | Novartis Ag | Combinations comprising epothilones and pharmaceutical uses thereof |
| WO2003077903A1 (en) * | 2002-03-12 | 2003-09-25 | Bristol-Myers Squibb Company | C12-cyano epothilone derivatives |
| SI1503756T1 (sl) * | 2002-05-01 | 2010-01-29 | Novartis Ag | Epotilonski derivat za zdravljenje hepatoma in drugih rakavih bolezni |
| EP1581218A1 (en) * | 2002-12-05 | 2005-10-05 | Schering AG | Epothilone analogs for site specific delivery in the treatment of proliferative diseases |
| GB0305928D0 (en) * | 2003-03-14 | 2003-04-23 | Novartis Ag | Organic compounds |
| EP1475105A1 (en) * | 2003-05-09 | 2004-11-10 | Schering AG | Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy |
| MXPA05013958A (es) * | 2003-06-27 | 2006-02-24 | Novartis Ag | Tratamiento de cancer con epotilona. |
| MXPA06002393A (es) * | 2003-09-02 | 2006-06-20 | Novartis Ag | Tratamiento de cancer con epotilomas. |
-
2004
- 2004-09-24 EP EP04090377A patent/EP1640004A1/en not_active Withdrawn
-
2005
- 2005-09-22 EP EP05788787A patent/EP1809281A2/en not_active Withdrawn
- 2005-09-22 WO PCT/EP2005/010400 patent/WO2006032537A2/en not_active Ceased
- 2005-09-22 PA PA20058646201A patent/PA8646201A1/es unknown
- 2005-09-22 CN CNA2005800402761A patent/CN101065126A/zh active Pending
- 2005-09-22 BR BRPI0516080-4A patent/BRPI0516080A/pt not_active IP Right Cessation
- 2005-09-22 KR KR1020077006651A patent/KR20070054214A/ko not_active Withdrawn
- 2005-09-22 AU AU2005287477A patent/AU2005287477A1/en not_active Abandoned
- 2005-09-22 JP JP2007532855A patent/JP2008514569A/ja active Pending
- 2005-09-22 MX MX2007003503A patent/MX2007003503A/es not_active Application Discontinuation
- 2005-09-22 RU RU2007115162/15A patent/RU2007115162A/ru not_active Application Discontinuation
- 2005-09-22 CA CA002580215A patent/CA2580215A1/en not_active Abandoned
- 2005-09-23 UY UY29136A patent/UY29136A1/es not_active Application Discontinuation
- 2005-09-23 TW TW094133125A patent/TW200626150A/zh unknown
- 2005-09-23 GT GT200500267A patent/GT200500267A/es unknown
- 2005-09-23 PE PE2005001103A patent/PE20060695A1/es not_active Application Discontinuation
- 2005-09-26 AR ARP050104007A patent/AR051035A1/es unknown
-
2007
- 2007-03-07 IL IL181785A patent/IL181785A0/en unknown
- 2007-04-11 EC EC2007007390A patent/ECSP077390A/es unknown
- 2007-04-19 CR CR9064A patent/CR9064A/es not_active Application Discontinuation
- 2007-04-23 NO NO20072099A patent/NO20072099L/no not_active Application Discontinuation
- 2007-04-23 ZA ZA200703306A patent/ZA200703306B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200626150A (en) | 2006-08-01 |
| PA8646201A1 (es) | 2006-11-09 |
| GT200500267A (es) | 2006-06-06 |
| EP1809281A2 (en) | 2007-07-25 |
| ZA200703306B (en) | 2010-06-30 |
| MX2007003503A (es) | 2007-08-17 |
| EP1640004A1 (en) | 2006-03-29 |
| CR9064A (es) | 2007-10-01 |
| CN101065126A (zh) | 2007-10-31 |
| UY29136A1 (es) | 2006-04-28 |
| RU2007115162A (ru) | 2008-11-20 |
| ECSP077390A (es) | 2007-05-30 |
| WO2006032537A2 (en) | 2006-03-30 |
| NO20072099L (no) | 2007-04-23 |
| KR20070054214A (ko) | 2007-05-28 |
| JP2008514569A (ja) | 2008-05-08 |
| WO2006032537A3 (en) | 2006-05-04 |
| IL181785A0 (en) | 2007-07-04 |
| CA2580215A1 (en) | 2006-03-30 |
| AR051035A1 (es) | 2006-12-13 |
| AU2005287477A1 (en) | 2006-03-30 |
| BRPI0516080A (pt) | 2008-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080548A1 (es) | Derivados de [4,5']bipirimidinil-6,4'-diamina como inhibidores de cinasa de proteina | |
| GT200300059A (es) | Compuestos utiles en terapia | |
| PE20040747A1 (es) | Nuevos conjugados de efectores y procedimientos para su preparacion | |
| PE20151249A1 (es) | Derivados de pirazolopirimidina como inhibidores de jak quinasas | |
| CY1107475T1 (el) | Αναστολεις ρο-κινασης | |
| AR040971A1 (es) | Compuestos pirimido que tienen actividad antiproliferativa | |
| PE20081800A1 (es) | NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA | |
| AR045595A1 (es) | Composiciones utiles como inhibidores de proteinas quinasas | |
| PE20050142A1 (es) | 2-hidroxi-3-diaminoalcanos de benzamida | |
| PE20051061A1 (es) | 5,7-DIAMINOPIRAZOLO[4,3-d] PIRIMIDINAS | |
| PE20091116A1 (es) | Derivados de piridina y pirazina como inhibidores de tirosina quinasas | |
| CY1109376T1 (el) | Παραγωγα υδαντοϊνης χρησιμα ως αναστολεις μεταλλοπρωτεϊνασης | |
| ECSP045368A (es) | "antagonistas de los receptores de trombina" | |
| ATE464049T1 (de) | Pharmazeutische kombinationen von hydrocodon und naltrexon | |
| DE60228406D1 (de) | PYRAZOLOÄ3,4-dÜPYRIMIDINDERIVATE UND IHRE VERWENDUNG ALS ANTAGONISTEN DES PURINERGEN REZEPTORS | |
| PE69298A1 (es) | Inhibidores de metaloproteinasas, composiciones farmaceuticas que los contienen y sus usos farmaceuticos y los metodos e intermedios utiles para su preparacion | |
| EP1662994A4 (en) | IMPLANTABLE BIOSENSOR DEVICES FOR MONITORING HERZMARKER MOLECULES | |
| CO5580788A2 (es) | Compuestos de bencimidazol sustituidos utiles como inhibidores de proteina cinasas | |
| CY1107196T1 (el) | Υποκατεστημενα παραγωγα 2,4-διϋδρο-πυρρολο (3,4-β) -κινολιν-9-ονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| PH12012501362A1 (en) | Benzazepine derivatives useful as vasopressin antagonists | |
| NO20053530L (no) | Multivalente lymfotoksin-beta-reseptorantagonister samt anvendelse derav | |
| ATE487715T1 (de) | Triazolderivate als modulatoren von dopamin-d3- rezeptoren | |
| PE20070621A1 (es) | 2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidina-5-onas | |
| PE20091083A1 (es) | Moduladores tieno- y furo- pirimidina del receptor de histamina h4 | |
| BR0313385A (pt) | Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |